PHOENIXBIO CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 493 JPY | 0.00% |
|
-0.60% | +5.79% |
| Sales 2022 | 1.32B 8.43M | Sales 2023 | 2.12B 13.52M | Capitalization | 2.23B 14.23M |
|---|---|---|---|---|---|
| Net income 2022 | -387M -2.46M | Net income 2023 | 493M 3.14M | EV / Sales 2022 | 1.09 x |
| Net cash position 2022 | 288M 1.83M | Net cash position 2023 | 426M 2.71M | EV / Sales 2023 | 0.85 x |
| P/E ratio 2022 |
-4.47
x | P/E ratio 2023 |
6.32
x | Employees | 65 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 44.09% |
More Fundamentals
* Assessed data
More news
| 1 week | -0.60% | ||
| Current month | +3.57% | ||
| 1 month | +3.14% | ||
| 3 months | +3.35% | ||
| 6 months | +2.92% | ||
| Current year | +5.79% |
1 week
481.00
511.00
1 month
467.00544.00
Current year
457.00580.00
1 year
442.00628.00
3 years
442.00834.00
5 years
442.001 490.00
10 years
442.003 775.00
| Managers | Title | Age | Since |
|---|---|---|---|
Takashi Shimada
PSD | President | 65 | 02-03-03 |
Kenji Kuramoto
CHM | Chairman | 67 | 05-10-31 |
| Chief Tech/Sci/R&D Officer | 62 | 07-03-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Kenji Kuramoto
CHM | Chairman | 67 | 05-10-31 |
Takashi Shimada
PSD | President | 65 | 02-03-03 |
Yasuhiro Tamura
ADM | Chief Administrative Officer | 67 | 04-03-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-24 | 493 | 0.00% | 9 900 |
| 24-05-23 | 493 | +1.44% | 3,200 |
| 24-05-22 | 486 | 0.00% | 3,200 |
| 24-05-21 | 486 | -1.02% | 7,200 |
| 24-05-20 | 491 | -1.01% | 1,600 |
Delayed Quote Japan Exchange, May 24, 2024 at 12:42 am EDT
More quotes
PhoenixBio Co., Ltd. is a Japan-based company mainly engaged in provision of contract research services of drug development, which uses PXB mouse. The PXB Mouse segment is engaged in the development of technology to create PXB Mouse in which more than 70% of mouse livers are replaced with human hepatocytes. The product called PXB Mouse is used in the preclinical process of the discovery of drugs.
Calendar
2024-08-08
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +5.79% | 12.64M | |
| +64.92% | 62.86B | |
| -1.85% | 41.38B | |
| +46.11% | 40.38B | |
| -8.93% | 27.64B | |
| +13.05% | 26.46B | |
| -21.96% | 18.9B | |
| +4.21% | 12.67B | |
| +25.74% | 12.27B | |
| +27.42% | 12.07B |
- Stock Market
- Equities
- 6190 Stock
